کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3019677 | 1182251 | 2007 | 9 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Stents recubiertos en el infarto agudo de miocardio
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
FVIfunción ventricular izquierdaRLTActPFVTSNRAVEPESSECSES - آنAngioplastia primaria - آنژیوپلاستی اولیهdrug-eluting stent - استنت سم زداییstent recubierto - استنت پوشش داده شدهSociedad Española de Cardiología - انجمن قلبشناسی اسپانیاInfarto agudo de miocardio - انفارکتوس حاد قلبAcute myocardial infarction - سکته قلبیIAM - من هستمaci - چشم
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
کاردیولوژی و پزشکی قلب و عروق
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Despite apparent advances in the use of stents for percutaneous coronary intervention, the target lesion revascularization (TLR) rate remains around 8% and the binary restenosis rate remains around 25% in patients undergoing primary percutaneous transluminal coronary angioplasty with bare metal stents. Preliminary results with drug-eluting stents in nonrandomized studies confirm that their use does not significantly reduce the mortality rate but does lead to significant reductions in TLR and binary restenosis rates. Randomized studies of stent efficacy have shown that the use of drug-eluting stents decreases the TLR rate between 30-60%, depending of the rate observed with bare metal stents. This reduction is not accompanied by a decrease in either mortality or acute myocardial infarction recurrence. The significant reduction in major adverse cardiac events observed is due to a reduction in one type of event: TLR. The restenosis rate is also significantly less with drugeluting than bare metal stents. With regard to safety, it can be concluded that there is no significant difference between drug-eluting and bare metal stents in either acute, subacute or late stent thrombosis. However, the lengths of the studies were such that no data were available on very late stent thrombosis. Neither were there sufficient data to conclude that one type of drug-eluting stent was better than any other.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Revista Española de CardiologÃa Suplementos - Volume 7, Issue 5, 2007, Pages 63E-71E
Journal: Revista Española de CardiologÃa Suplementos - Volume 7, Issue 5, 2007, Pages 63E-71E
نویسندگان
Mariano Valdés-Chávarri,